跳至主要内容
临床试验/ISRCTN13727958
ISRCTN13727958已完成未知

Randomized controlled trial to assess the early addition of exogenous surfactant to inhaled nitric oxide in the treatment of newborns with respiratory failure and pulmonary hypertension

Pontificia Universidad Católica de Chile0 个研究点目标入组 100 人开始时间: 2019年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

2020 results in https://doi.org/10.1038/s41372-020-00777-x (added 26/08/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Near term infants (35 weeks gestation) with birth weights > 2000 g and who are less than 72 hours old
  • 2. Infants requiring mechanical ventilation with hypoxemic respiratory failure with an OI > 20, calculated on two consecutive measurements of post ductal arterial blood gases without acidosis (pH > 7.25) and efforts will be done to adjust ventilatory support to reach a PCO2 < 60
  • 3. A previous echocardiogram will be performed to rule out a cardiac anomaly and evaluate the presence of pulmonary hypertension (a tricuspid insufficiency jet with an estimated systolic pulmonary artery pressure = 2/3 of systemic systolic arterial blood pressure and/or evidence of right-to-left shunting through foramen ovale or ductus arteriosus)

排除标准

  • 1. Life-threatening congenital anomalies
  • 2. Congenital heart disease
  • 3. Congenital diaphragmatic hernia
  • 4. Other forms of lung hypoplasia syndromes
  • 5. Suspected or confirmed chromosomal abnormality
  • 6. Postnatal age > 72 hours

研究者

相似试验